NASA
Note: The Concern of Venous Thromboembolism is historical and now a component of CV Risk.
Stagnant or reverse flow in the internal jugular vein has been observed in 6 of 11 crew members (55%) tested in-mission on approximately flight day 50; one crewmember was found to have an occlusive internal jugular vein thrombus requiring treatment in-mission. This is an emerging finding and has potential impacts on flight participants with cardiovascular conditions.
Directed Acyclic Graph Files
Visit the CV Risk page for Concern of Venous Thromboembolism DAG Files.